Saturday 17 October 2026 Export VIR’s income statement to Excel — free account

Vir Biotechnology, Inc.

Vir Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $68.6 million, down 7.61% from fiscal 2024. In the quarter to June 2026, revenue grew 19,582.5%, EPS grew 160.0% and free cash flow grew 200.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

9.96 0.51 −4.87%

Follow VIR

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −5.9×
Dividend yield: —
F-score: 4/9
Altman Z: −0.57
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	5	4	4	2	+8 more TTM periods Free account
ROE Full definition →	(26.08%)	(47.69%)	(45.73%)	(49.06%)
ROA Full definition →	(20.91%)	(37.95%)	(36.47%)	(39.69%)
ROIC Full definition →	(39.10%)	(88.19%)	(101.09%)	(119.31%)
Return on Tangible Assets Full definition →	(47.56%)	(88.09%)	(91.84%)	(94.51%)
Average Days of Receivables Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(1.21)	(3.05)	(2.86)	(3.29)
Free Cash Flow Full definition →	(203.67)	(449.67)	(396.36)	(457.20)
Capital Expenditures Full definition →	(1.16)	(3.62)	(4.58)	(3.66)
Other line items
Cash ROIC Full definition →	(13.42%)	(34.83%)	(32.11%)	(35.04%)
Accounts Receivable Turnover Full definition →	0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.10	0.10
Inventory Turnover Full definition →	—	—	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	5,039.57	3,404.84
Days of Inventory on Hand Full definition →	—	—	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	159.62%	681.34%	665.10%	2,809.61%
Selling, General and Administrative Expense of Revenue Full definition →	32.77%	139.66%	134.30%	564.41%
Share Based Compensation of Revenue Full definition →	15.51%	71.91%	71.58%	318.55%
Operating CF/Net income Full definition →	0.80	1.01	0.89	0.91
Depreciation/Fixed assets Full definition →	0.30	0.33	0.38	0.37
Capex/Depreciation Full definition →	(0.08)	(0.21)	(0.22)	(0.17)
Revenue per Share Full definition →	1.81	0.44	0.49	0.12
Operating CF per Share Full definition →	(1.21)	(3.03)	(2.83)	(3.26)
Capex per Share Full definition →	(0.01)	(0.02)	(0.03)	(0.03)
Capex to Sales Full definition →	0.00	0.06	0.07	0.22

Show all line items

Columns are period end dates

Stockrow Weekly